arrow_right
Clinical Validation
PIVOTAL CLINICAL
VALIDATION STUDY
RESULTS
In a prospective, multicenter clinical validation study, Envisia classifier identified UIP with a specificity of 88%.11 In addition, the classifier demonstrated sensitivity of 70%, versus 43% with HRCT alone.
LINK TO STUDY
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name
Last Name
Email
Institution
Zip Code
Which Test Interests You?
More About You
Message
CONTACT REP
R E F E R E N C E S
11. Raghu G, et al. Lancet Respiratory Medicine. 2019
© 2020 Veracyte, Inc. All rights reserved.